Tirzepatide Providers We Review

Two telehealth providers currently offer compounded tirzepatide through online consultations: BiltRx and Arc-1. Both require a medical evaluation before dispensing. Both sell injectable-only formulations. Neither product is FDA-approved. This page summarizes each provider's strengths, weaknesses and the type of patient each one suits best.

BiltRx

BiltRx offers compounded tirzepatide at $129 per month through a US 503A compounding pharmacy. It also lists brand-name Mounjaro and Zepbound at $1,499 per month. The online consultation model is standard for telehealth platforms. Monthly delivery keeps the refill process simple.

The strength is price. At $129 per month for compounded tirzepatide, BiltRx is the least expensive provider we track. No state restrictions are listed, which means patients nationwide can access the service. The availability of brand-name options alongside the compounded product gives patients flexibility to switch if they prefer an FDA-approved formulation.

The weakness is transparency. BiltRx does not publish dose-tier pricing, formulation specifics or a clear breakdown of consultation and shipping fees on its public pages. Patients cannot calculate their true monthly cost before entering the ordering process. There is no advertised money-back guarantee. For patients who prioritize low cost above all else and are comfortable asking questions during the consultation, BiltRx delivers strong value. Read the full assessment in our BiltRx compounded tirzepatide review.

Arc-1

Arc-1 sells compounded tirzepatide combined with glycine and vitamin B12 at dose-tiered prices: $199.99 for 2.5 mg, $249.99 for 5 mg and $399.99 for 7.5 mg. The consultation is free. Shipping is free. A 30-day money-back guarantee comes with every order. Arc-1 holds LegitScript certification, which confirms it passed a third-party review of its licensing and telehealth practices.

The strength is transparency and bundled value. Published dose-tier pricing means no hidden fees. The formulation breakdown is listed clearly: 10 mg tirzepatide, 5 mg glycine and 500 mcg B12 per milliliter. LegitScript certification adds a layer of verification that most competitors lack. The 30-day guarantee reduces the financial risk for new patients.

The weakness is cost and geographic coverage. Arc-1 is more expensive than BiltRx at every dose level, and the jump to $399.99 at 7.5 mg is steep. Pricing above 7.5 mg is not published. Patients in California, Arkansas, Indiana, Minnesota and South Carolina cannot order. For patients who want clarity on what they are paying for and a safety net if the product does not work out, Arc-1 is the stronger option. Read the full assessment in our Arc-1 compounded tirzepatide review.